심정지 치료 시장 규모, 점유율, 성장 분석 : 치료법별, 의료기기 종류별, 약제 종류별, 심정지 발생 장소별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Cardiac Arrest Treatment Market size was valued at USD 5.5 Billion in 2024 and is poised to grow from USD 5.75 Billion in 2025 to USD 8.15 Billion by 2033, growing at a CAGR of 4.47% during the forecast period (2026-2033).

The global cardiac arrest treatment market includes a range of devices, medications, and emergency services aimed at restoring circulation following sudden cardiac arrest, a leading cause of death worldwide. The growing prevalence of cardiac events, driven by aging populations and lifestyle-related risk factors, significantly fuels demand for innovative solutions. The evolution from basic defibrillators to advanced automated external defibrillators (AEDs) highlights the market's progression. Regulatory support for early defibrillation mandates placement in various public settings, creating further opportunities for manufacturers. Additionally, the integration of AI into devices enhances arrhythmia prediction and response efficiency, positioning manufacturers to meet the growing need for technology-driven solutions. Overall, as awareness and technology advance, the market is primed for continued growth and improved health outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cardiac Arrest Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cardiac Arrest Treatment Market Segments Analysis

Global cardiac arrest treatment market is segmented by treatment modality, medical device type, medication class, cardiac arrest location, end user and region. Based on treatment modality, the market is segmented into Medical Devices, Pharmaceuticals, Therapeutic Hypothermia and Surgical Interventions. Based on medical device type, the market is segmented into Automated External Defibrillators, Advanced Life Support Defibrillators, Wearable Cardioverter Defibrillators and Mechanical Cardiopulmonary Resuscitation Devices. Based on medication class, the market is segmented into Vasopressors, Antiarrhythmic Drugs and Anticholinergic Agents. Based on cardiac arrest location, the market is segmented into Out of Hospital Cardiac Arrest and In Hospital Cardiac Arrest. Based on end user, the market is segmented into Hospitals, Cardiac Care Centers, Emergency Medical Services and Ambulatory Care Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cardiac Arrest Treatment Market

The rising awareness surrounding cardiac arrest through various initiatives is effectively training the public to recognize symptoms and take prompt action, resulting in a culture where bystanders are more willing to step in during emergencies. This increased preparedness broadens the number of potential responders, enabling quicker administration of lifesaving measures prior to the arrival of medical professionals. Furthermore, these awareness campaigns not only foster community involvement but also create a heightened demand for readily available therapeutic devices and training programs. Consequently, this trajectory promotes market growth across diverse regions, strengthens public health priorities, and urges policymakers to invest in emergency response systems.

Restraints in the Global Cardiac Arrest Treatment Market

The advanced technology embedded in contemporary cardiac arrest treatment devices, which often includes integrated monitoring and automated analysis functionalities, comes with high costs that many healthcare facilities, especially those in resource-limited areas, struggle to afford. This financial hurdle inhibits the widespread adoption of essential lifesaving equipment in regions most in need of prompt medical intervention. As a result, healthcare providers may delay or opt out of investing in these innovative solutions, which not only hampers market penetration but also restricts overall growth potential in various locations. Consequently, this diminishes manufacturers' motivation to focus on regional distribution efforts.

Market Trends of the Global Cardiac Arrest Treatment Market

The Global Cardiac Arrest Treatment market is witnessing a dynamic shift towards the integration of AI-driven early detection systems within emergency medical response frameworks. Healthcare providers are leveraging advanced artificial intelligence algorithms to analyze electrocardiogram patterns swiftly, enhancing real-time risk stratification. These innovative tools utilize extensive data sets to detect subtle arrhythmic signatures that might be overlooked during manual interpretations. As clinicians gain confidence in AI-assisted diagnostics, the adoption of such technologies is spreading across both urban and rural healthcare networks, significantly shortening the critical timeline from patient collapse to definitive treatment and ultimately improving survival rates without dependence on costly capital equipment.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Cardiac Arrest Treatment Market Size by Treatment Modality & CAGR (2026-2033)

• Market Overview
• Medical Devices
• Pharmaceuticals
• Therapeutic Hypothermia
• Surgical Interventions

Global Cardiac Arrest Treatment Market Size by Medical Device Type & CAGR (2026-2033)

• Market Overview
• Automated External Defibrillators
• Advanced Life Support Defibrillators
• Wearable Cardioverter Defibrillators
• Mechanical Cardiopulmonary Resuscitation Devices

Global Cardiac Arrest Treatment Market Size by Medication Class & CAGR (2026-2033)

• Market Overview
• Vasopressors
  • Epinephrine
  • Vasopressin
• Antiarrhythmic Drugs
  • Amiodarone
  • Lidocaine
• Anticholinergic Agents
  • Atropine

Global Cardiac Arrest Treatment Market Size by Cardiac Arrest Location & CAGR (2026-2033)

• Market Overview
• Out of Hospital Cardiac Arrest
• In Hospital Cardiac Arrest

Global Cardiac Arrest Treatment Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Cardiac Care Centers
• Emergency Medical Services
• Ambulatory Care Centers

Global Cardiac Arrest Treatment Market Size & CAGR (2026-2033)

• North America (Treatment Modality, Medical Device Type, Medication Class, Cardiac Arrest Location, End User)
  • US
  • Canada
• Europe (Treatment Modality, Medical Device Type, Medication Class, Cardiac Arrest Location, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Treatment Modality, Medical Device Type, Medication Class, Cardiac Arrest Location, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Treatment Modality, Medical Device Type, Medication Class, Cardiac Arrest Location, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Treatment Modality, Medical Device Type, Medication Class, Cardiac Arrest Location, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Amgen Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Viatris Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim International GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceutical Company Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson Services, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dr. Reddy's Laboratories Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cipla Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lupin Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hikma Pharmaceuticals PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sandoz Group AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Kasei Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations